These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1240 related articles for article (PubMed ID: 11483342)

  • 21. Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer.
    Janjan NA; Crane CN; Feig BW; Cleary K; Dubrow R; Curley SA; Ellis LM; Vauthey J; Lenzi R; Lynch P; Wolff R; Brown T; Pazdur R; Abbruzzese J; Hoff PM; Allen P; Brown B; Skibber J
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):713-8. PubMed ID: 10837955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiotherapy, concomitant protracted-venous-infusion 5-fluorouracil, and surgery for ultrasound-staged T3 or T4 rectal cancer.
    Mehta VK; Poen J; Ford J; Edelstein PS; Vierra M; Bastidas AJ; Young H; Fisher G
    Dis Colon Rectum; 2001 Jan; 44(1):52-8. PubMed ID: 11805563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pilot study of preoperative continuous infusion 5-fluorouracil, external microwave hyperthermia, and external beam radiotherapy for treatment of locally advanced, unresectable, or recurrent rectal cancer.
    Anscher MS; Lee C; Hurwitz H; Tyler D; Prosnitz LR; Jowell P; Rosner G; Samulski T; Dewhirst MW
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):719-24. PubMed ID: 10837956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO-94.
    Sauer R; Fietkau R; Wittekind C; Rödel C; Martus P; Hohenberger W; Tschmelitsch J; Sabitzer H; Karstens JH; Becker H; Hess C; Raab R;
    Colorectal Dis; 2003 Sep; 5(5):406-15. PubMed ID: 12925071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II study of preoperative helical tomotherapy with a simultaneous integrated boost for rectal cancer.
    Engels B; Tournel K; Everaert H; Hoorens A; Sermeus A; Christian N; Storme G; Verellen D; De Ridder M
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):142-8. PubMed ID: 22014952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative chemoradiotherapy and radical surgery for locally advanced distal rectal adenocarcinoma: pathologic findings and clinical implications.
    Medich D; McGinty J; Parda D; Karlovits S; Davis C; Caushaj P; Lembersky B
    Dis Colon Rectum; 2001 Aug; 44(8):1123-8. PubMed ID: 11535851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study.
    Caravatta L; Padula GD; Picardi V; Macchia G; Deodato F; Massaccesi M; Sofo L; Pacelli F; Rotondi F; Cecere G; Sallustio G; Di Lullo L; Piscopo A; Mignogna S; Bonomo P; Cellini N; Valentini V; Morganti AG
    Acta Oncol; 2011 Nov; 50(8):1151-7. PubMed ID: 21851185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I study of 5-fluorouracil and leucovorin by continuous infusion chronotherapy and pelvic radiotherapy in patients with locally advanced or recurrent rectal cancer.
    Parulekar W; de Marsh RW; Wong R; Mendenhall W; Davey P; Zlotecki R; Berry S; Rout WR; Bjarnason GA
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1487-95. PubMed ID: 15050328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pretreatment clinical findings predict outcome for patients receiving preoperative radiation for rectal cancer.
    Myerson RJ; Singh A; Birnbaum EH; Fry RD; Fleshman JW; Kodner IJ; Lockett MA; Picus J; Walz BJ; Read TE
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):665-74. PubMed ID: 11395234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Five fractions of preoperative radiotherapy for selected cases of rectal carcinoma: long-term tumor control and tolerance to treatment.
    Myerson RJ; Genovesi D; Lockett MA; Birnbaum E; Fleshman J; Fry R; Kodner I; Menteer J; Picus J; Read T; Walz B
    Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):537-43. PubMed ID: 10078634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-dose radiotherapy and concurrent UFT plus l-leucovorin in locally advanced rectal cancer: a phase I trial.
    Pfeiffer P
    Acta Oncol; 2005; 44(3):224-9. PubMed ID: 16076693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-grade acute organ toxicity during preoperative radiochemotherapy as positive predictor for complete histopathologic tumor regression in multimodal treatment of locally advanced rectal cancer.
    Wolff HA; Gaedcke J; Jung K; Hermann RM; Rothe H; Schirmer M; Liersch T; Herrmann MKA; Hennies S; Rave-Fränk M; Hess CF; Christiansen H
    Strahlenther Onkol; 2010 Jan; 186(1):30-35. PubMed ID: 20082185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative capecitabine and pelvic radiation in locally advanced rectal cancer--is it equivalent to 5-FU infusion plus leucovorin and radiotherapy?
    Chan AK; Wong AO; Jenken DA
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1413-9. PubMed ID: 20338475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Raltitrexed and radiotherapy as adjuvant treatment for stage II-III rectal cancer: a feasibility study.
    Lupattelli M; Maranzano E; Bellavita R; Natalini G; Corgna E; Rossetti R; Trippa F; Mascioni F; Sidoni A; Anselmo P; Buzzi F; Brugia M; Latini P
    Tumori; 2005; 91(6):498-504. PubMed ID: 16457149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [First results of neoadjuvant simultaneious radiochemotherapy in advanced rectal carcinoma].
    Küchenmeister U; Kirchner R; Mellert J; Klautke G; Mücke R; Hopt UT; Fietkau R
    Strahlenther Onkol; 2000 Dec; 176(12):560-6. PubMed ID: 11140150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative radio-chemotherapy (RT-CT) in rectal cancer. Prospective study with postoperative RT-CT control group.
    Cambray i Amenós M; Navarro García M; Martí Ragué J; Pareja Fernández L; Pera Fábregas J
    Clin Transl Oncol; 2007 Mar; 9(3):183-91. PubMed ID: 17403630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early toxicity from preoperative radiotherapy with continuous infusion 5-fluorouracil for resectable adenocarcinoma of the rectum: a Phase II trial for the Trans-Tasman Radiation Oncology Group.
    Ngan SY; Burmeister BH; Fisher R; Rischin D; Schache DJ; Kneebone A; MacKay JR; Joseph D; Bell A; Goldstein D
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):883-7. PubMed ID: 11429215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial.
    Gérard JP; Chapet O; Nemoz C; Romestaing P; Mornex F; Coquard R; Barbet N; Atlan D; Adeleine P; Freyer G
    J Clin Oncol; 2003 Mar; 21(6):1119-24. PubMed ID: 12637479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Local excision and postoperative radiotherapy for distal rectal cancer.
    Benson R; Wong CS; Cummings BJ; Brierley J; Catton P; Ringash J; Abdolell M
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1309-16. PubMed ID: 11483343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of the comparative toxicity of 5-FU bolus versus 5-FU continuous infusion circadian chemotherapy with concurrent radiation therapy in locally advanced rectal cancer.
    Thrall MM; Wood P; King V; Rivera W; Hrushesky W
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):873-81. PubMed ID: 10705008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.